Skip to content

Fluorescence-navigated Thoracoscopy for Pulmonary Segmentectomy

Fluorescence-navigated Thoracoscopy for Pulmonary Segmentectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04160884
Enrollment
68
Registered
2019-11-13
Start date
2018-12-12
Completion date
2021-06-30
Last updated
2019-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Segmentectomy

Brief summary

Recently developed fluorescence-navigated thoracoscopy with indocyanine green (ICG) is being used for various kinds of pulmonary surgery, and several studies have reported the application of this novel technique in demarcation of the intersegmental border for segmentectomy. This study is performed prospectively to find out, for the first time, the optimal dosage of ICG in human body to ensure safe and sustained imaging during segmentectomy.

Interventions

PROCEDUREIndocyanine Green Injection through Peripheral Vein

After ligation of the segmental pulmonary artery supplying the targeted segment, indocyanine is injected intravenously at a specific concentration intraoperatively.

Sponsors

Beijing Municipal Science & Technology Commission
CollaboratorOTHER
Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Suitable for segmentectomy and signed informed consent

Exclusion criteria

* Liver dysfunction. * Allergic to indocyanine green. * Can't tolerate thoracoscopic surgery.

Design outcomes

Primary

MeasureTime frameDescription
Signal-to-background Ratio (SBR) of the Targeted and Non-targeted SegmentsSurgeryWe use image analysis software ImageJ to evaluate the strength of luminosity in the targeted and non-target segments using intraoperative images and calculate signal-to-background-ratio.

Countries

China

Contacts

Primary ContactFeng Yang, MD
yangfeng1007@sina.com(+86) 18612978269
Backup ContactTiezheng Li, MD
tiezhengli@foxmail.com(+86) 18811768786

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026